A systematic review of re-induction chemotherapy for children with relapsed high-risk neuroblastoma

BACKGROUND: Despite aggressive multimodal therapy, >50% of children with high-risk neuroblastoma (HRNB) relapse. Survival after relapse is rare, and no consensus currently exists on the most effective therapy. OBJECTIVE: To conduct a systematic review of the literature on effectiveness of re-indu...

Descripción completa

Detalles Bibliográficos
Autores principales: Herd, Fiona, Basta, Nermine O., McNally, Richard J.Q., Tweddle, Deborah A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458963/
https://www.ncbi.nlm.nih.gov/pubmed/30822684
http://dx.doi.org/10.1016/j.ejca.2018.12.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458963/
https://www.ncbi.nlm.nih.gov/pubmed/30822684
http://dx.doi.org/10.1016/j.ejca.2018.12.032

Ejemplares similares